Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension
Part of paid clinical trials in Daphne, Alabama.
- Sponsor
- Merck Sharp & Dohme LLC
- Study ID
- NCT06492291
- Phase
- PHASE3
- Status
- Active Not Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Enlicitide Decanoate — DRUGOral tablet
Study Details
This is an extension study to evaluate the longer-term safety and efficacy of enlicitide decanoate in adults with hypercholesterolemia who completed either study MK-0616-013 (NCT05952856), study MK-0616-017 (NCT05952869), or study MK-0616-018 (NCT06450366).
Key Dates
- Start date
- Aug 5, 2024
- Status verified
- Oct 2025
- Primary completion
- Oct 13, 2028
- Completion
- Oct 13, 2028
Study Design
- Enrollment
- 3,000 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Enlicitide DecanoateParticipants will receive 20 mg of enlicitide decanoate orally once daily (QD)
Primary Outcome Measure
Number of participants with one or more adverse events (AEs) [ Time Frame: Up to approximately 3 years ]
Locations (52)
Find similar trials in Daphne, AL
By research site
Alliance for Multispecialty Research, LLC· Daphne, ALG&L Research· Foley, ALSynexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix· Phoenix, AZNational Heart Institute-Research· Beverly Hills, CAClinical Trials Research· Sacramento, CAVelocity Clinical Research, Banning· San Bernardino, CA
Related Studies
- Causes and Natural History of DyslipidemiasRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Alirocumab in Patients on a Stable Dialysis RegimenPHASE3 · Recruiting · Baylor Research Institute · Dallas, Texas
- Pharmacogenomic Informed Statin PrescribingRecruiting · VA Office of Research and Development · Indianapolis, Indiana
- Vascular Intervention Strategies Trial for Alzheimer'sPHASE2 · Not Yet Recruiting · University of Southern California · Los Angeles, California